AUGMENTIN XR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Augmentin Xr, and when can generic versions of Augmentin Xr launch?
Augmentin Xr is a drug marketed by Us Antibiotics and is included in one NDA.
The generic ingredient in AUGMENTIN XR is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Augmentin Xr
A generic version of AUGMENTIN XR was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AUGMENTIN XR?
- What are the global sales for AUGMENTIN XR?
- What is Average Wholesale Price for AUGMENTIN XR?
Summary for AUGMENTIN XR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 15 |
Clinical Trials: | 75 |
Patent Applications: | 705 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AUGMENTIN XR |
DailyMed Link: | AUGMENTIN XR at DailyMed |
![AUGMENTIN XR drug patent expirations Drug patent expirations by year for AUGMENTIN XR](/p/graph/s/t/AUGMENTIN_XR-patent-expirations.png)
![Drug Prices for AUGMENTIN XR](/p/graph/drug-price/AUGMENTIN+XR.png)
Recent Clinical Trials for AUGMENTIN XR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Penn State College of Medicine | Phase 4 |
University of Wisconsin, Madison | Phase 4 |
Patient-Centered Outcomes Research Institute | Phase 4 |
Paragraph IV (Patent) Challenges for AUGMENTIN XR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AUGMENTIN XR | Extended-release Tablets | amoxicillin; clavulanate potassium | 1000 mg/62.5 mg | 050785 | 1 | 2009-01-21 |
US Patents and Regulatory Information for AUGMENTIN XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AUGMENTIN XR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | ⤷ Sign Up | ⤷ Sign Up |
Us Antibiotics | AUGMENTIN XR | amoxicillin; clavulanate potassium | TABLET, EXTENDED RELEASE;ORAL | 050785-001 | Sep 25, 2002 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AUGMENTIN XR
See the table below for patents covering AUGMENTIN XR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 0122638 | ⤷ Sign Up | |
Argentina | 031068 | UNA FORMULACION FARMACEUTICA DE LIBERACION MODIFICADA QUE COMPRENDE AMOXICILINA Y CLAVULANATO DE POTASIO EN UNA RELACION DE 2:1 A 20:1, UN COMPRIMIDO EN CAPAS, EL USO DE LA AMOXICILINA Y EL CLAVULANATO DE POTASIO PARA LA FABRICACION DE UN MEDICAMENTO, UN EQUIPO Y GRANULOS COMPACTOS | ⤷ Sign Up |
Denmark | 200000602 | ⤷ Sign Up | |
Morocco | 25352 | ⤷ Sign Up | |
Denmark | 200000133 | ⤷ Sign Up | |
Taiwan | I235067 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |